Glycolic Acid

Glycolic Acid

SCHEMBL162066

ClCN1CCc2ccccc2CC1.O=C(O)CO

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTR1A P08908 2/20 0.46
DRD2 P14416 2/20 0.46
HTR2A P28223 2/20 0.46
HTR7 P34969 2/20 0.46
HRH1 P35367 2/20 0.46
DRD3 P35462 2/20 0.46
HTR2B P41595 2/20 0.46
SLC6A4 P31645 1/20 0.46
KDM4E B2RXH2 3/20 0.44
ALOX15 P16050 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL160931 0.90 HDAC1 (0.50) HDAC1HDAC6MEN1KMT2AHTR1A
Succinic Acid SCHEMBL161277 0.90 NOTUM (0.54) HDAC1HDAC6MEN1KMT2AHTR1A
Adipic Acid SCHEMBL161400 0.87 HTR7 (0.50) HDAC1HDAC6MEN1KMT2AHTR1A
SCHEMBL162670 0.85 MAOA (0.46) HDAC1HDAC6MEN1KMT2ADRD2
Maleic Acid SCHEMBL161823 0.85 MEN1 (0.46) HDAC1HDAC6MEN1KMT2AHTR1A
Fumaric Acid SCHEMBL159723 0.85 MEN1 (0.46) HDAC1HDAC6MEN1KMT2AHTR1A
Citric Acid SCHEMBL163929 0.85 ALDH1A1 (0.43) HDAC1HDAC6MEN1KMT2AHTR1A
Bromide SCHEMBL161201 0.83 MAOA (0.45) HDAC1HDAC6DRD2HTR7DRD3
Iodide SCHEMBL162027 0.83 MAOA (0.45) HDAC1HDAC6MEN1KMT2ADRD2
Alpha-Ketoglutaric Acid SCHEMBL162747 0.83 NOTUM (0.48) HDAC1HDAC6MEN1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030953-A1 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed